|
1
|
Geller DS and Gorlick R: Osteosarcoma: A
review of diagnosis, management, and treatment strategies. Clin Adv
Hematol Oncol. 8:705–718. 2010.
|
|
2
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wada T, Isu K, Takeda N, Usui M, Ishii S
and Yamawaki S: A preliminary report of neoadjuvant chemotherapy
NSH-7 study in osteosarcoma: Preoperative salvage chemotherapy
based on clinical tumor response and the use of granulocyte
colony-stimulating factor. Oncology. 53:221–227. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bednarek AK, Laflin KJ, Daniel RL, Liao Q,
Hawkins KA and Aldaz CM: WWOX, a novel WW domain-containing protein
mapping to human chromosome 16q23.3–24.1, a region frequently
affected in breast cancer. Cancer Res. 60:2140–2145.
2000.PubMed/NCBI
|
|
5
|
Ried K, Finnis M, Hobson L, Mangelsdorf M,
Dayan S, Nancarrow JK, Woollatt E, Kremmidiotis G, Gardner A,
Venter D, et al: Common chromosomal fragile site FRA16D sequence:
Identification of the FOR gene spanning FRA16D and homozygous
deletions and translocation breakpoints in cancer cells. Hum Mol
Genet. 9:1651–1663. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang NS, Pratt N, Heath J, Schultz L,
Sleve D, Carey GB and Zevotek N: Hyaluronidase induction of a WW
domain-containing oxidoreductase that enhances tumor necrosis
factor cytotoxicity. J Biol Chem. 276:3361–3370. 2001. View Article : Google Scholar
|
|
7
|
Paige AJ, Taylor KJ, Taylor C, Hillier SG,
Farrington S, Scott D, Porteous DJ, Smyth JF, Gabra H and Watson
JE: WWOX: A candidate tumor suppressor gene involved in multiple
tumor types. Proc Natl Acad Sci USA. 98:11417–11422. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kuroki T, Trapasso F, Shiraishi T, Alder
H, Mimori K, Mori M and Croce CM: Genetic alterations of the tumor
suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer
Res. 62:2258–2260. 2002.PubMed/NCBI
|
|
9
|
Driouch K, Prydz H, Monese R, Johansen H,
Lidereau R and Frengen E: Alternative transcripts of the candidate
tumor suppressor gene, WWOX, are expressed at high levels in human
breast tumors. Oncogene. 21:1832–1840. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yendamuri S, Kuroki T, Trapasso F, Henry
AC, Dumon KR, Huebner K, Williams NN, Kaiser LR and Croce CM: WW
domain containing oxidoreductase gene expression is altered in
non-small cell lung cancer. Cancer Res. 63:878–881. 2003.PubMed/NCBI
|
|
11
|
Aqeilan RI, Kuroki T, Pekarsky Y, Albagha
O, Trapasso F, Baffa R, Huebner K, Edmonds P and Croce CM: Loss of
WWOX expression in gastric carcinoma. Clin Cancer Res.
10:3053–3058. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kuroki T, Yendamuri S, Trapasso F,
Matsuyama A, Aqeilan RI, Alder H, Rattan S, Cesari R, Nolli ML,
Williams NN, et al: The tumor suppressor gene WWOX at FRA16D is
involved in pancreatic carcinogenesis. Clin Cancer Res.
10:2459–2465. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park SW, Ludes-Meyers J, Zimonjic DB,
Durkin ME, Popescu NC and Aldaz CM: Frequent downregulation and
loss of WWOX gene expression in human hepatocellular carcinoma. Br
J Cancer. 91:753–759. 2004.PubMed/NCBI
|
|
14
|
Pimenta FJ, Gomes DA, Perdigão PF, Barbosa
AA, Romano-Silva MA, Gomez MV, Aldaz CM, De Marco L and Gomez RS:
Characterization of the tumor suppressor gene WWOX in primary human
oral squamous cell carcinomas. Int J Cancer. 118:1154–1158. 2006.
View Article : Google Scholar
|
|
15
|
Bednarek AK, Keck-Waggoner CL, Daniel RL,
Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ and Aldaz CM: WWOX,
the FRA16D gene, behaves as a suppressor of tumor growth. Cancer
Res. 61:8068–8073. 2001.PubMed/NCBI
|
|
16
|
Fabbri M, Iliopoulos D, Trapasso F,
Aqeilan RI, Cimmino A, Zanesi N, Yendamuri S, Han SY, Amadori D,
Huebner K and Croce CM: WWOX gene restoration prevents lung cancer
growth in vitro and in vivo. Proc Natl Acad Sci USA.
102:15611–15616. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schirmer MA, Lüske CM, Roppel S, Schaudinn
A, Zimmer C, Pflüger R, Haubrock M, Rapp J, Güngör C, Bockhorn M,
et al: Relevance of Sp binding site polymorphism in WWOX for
treatment outcome in pancreatic cancer. J Natl Cancer Inst.
108:djv3872016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Del Mare S and Aqeilan RI: Tumor
Suppressor WWOX inhibits osteosarcoma metastasis by modulating
RUNX2 function. Sci Rep. 5:129592015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Calin GA and Croce CM: MicroRNA-cancer
connection: The beginning of a new tale. Cancer Res. 66:7390–7394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McManus MT: MicroRNAs and cancer. Semin
Cancer Biol. 13:253–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu CX, Xu M, Tan L, Yang H, Permuth-Wey J,
Kruk PA, Wenham RM, Nicosia SV, Lancaster JM, Sellers TA and Cheng
JQ: MicroRNA miR-214 regulates ovarian cancer cell stemness by
targeting p53/Nanog. J Biol Chem. 287:34970–34978. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li
M, Sun L, Ji G, Shi Y, Han Z, et al: miRNA-223 promotes gastric
cancer invasion and metastasis by targeting tumor suppressor
EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang XJ, Ye H, Zeng CW, He B, Zhang H and
Chen YQ: Dysregulation of miR-15a and miR-214 in human pancreatic
cancer. J Hematol Oncol. 3:462010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Z and Cai H, Lin L, Tang M and Cai H:
Upregulated expression of microRNA-214 is linked to tumor
progression and adverse prognosis in pediatric osteosarcoma.
Pediatr Blood Cancer. 61:206–210. 2014. View Article : Google Scholar
|
|
26
|
Xu Z and Wang T: miR-214 promotes the
proliferation and invasion of osteosarcoma cells through direct
suppression of LZTS1. Biochem Biophys Res Commun. 449:190–195.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lombaerts M, van Wezel T, Philippo K,
Dierssen JW, Zimmerman RM, Oosting J, van Eijk R, Eilers PH, van de
Water B, Cornelisse CJ and Cleton-Jansen AM: E-cadherin
transcriptional downregulation by promoter methylation but not
mutation is related to epithelial-to-mesenchymal transition in
breast cancer cell lines. Br J Cancer. 94:661–671. 2006.PubMed/NCBI
|
|
28
|
Shen A, Zhang Y, Yang H, Xu R and Huang G:
Overexpression of ZEB1 relates to metastasis and invasion in
osteosarcoma. J Surg Oncol. 105:830–834. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng CW, Wang HW, Chang CW, Chu HW, Chen
CY, Yu JC, Chao JI, Liu HF, Ding SL and Shen CY: MicroRNA-30a
inhibits cell migration and invasion by downregulating vimentin
expression and is a potential prognostic marker in breast cancer.
Breast Cancer Res Treat. 134:1081–1093. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gilles C, Polette M, Zahm JM, Tournier JM,
Volders L, Foidart JM and Birembaut P: Vimentin contributes to
human mammary epithelial cell migration. J Cell Sci. 112:4615–4625.
1999.PubMed/NCBI
|
|
31
|
Uygur B and Wu WS: SLUG promotes prostate
cancer cell migration and invasion via CXCR4/CXCL12 axis. Mol
Cancer. 10:1392011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD
and Wang LH: Twist transcriptionally up-regulates AKT2 in breast
cancer cells leading to increased migration, invasion, and
resistance to paclitaxel. Cancer Res. 67:1979–1987. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Burk U, Schubert J, Wellner U, Schmalhofer
O, Vincan E, Spaderna S and Brabletz T: A reciprocal repression
between ZEB1 and members of the miR-200 family promotes EMT and
invasion in cancer cells. EMBO Rep. 9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pasquinelli AE, Reinhart BJ, Slack F,
Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B,
Müller P, et al: Conservation of the sequence and temporal
expression of let-7 heterochronic regulatory RNA. Nature.
408:86–89. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
He L, He X, Lim LP, de Stanchina E, Xuan
Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al: A microRNA
component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Novakova J, Slaby O, Vyzula R and Michalek
J: MicroRNA involvement in glioblastoma pathogenesis. Biochem
Biophys Res Commun. 386:1–5. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sasayama T, Nishihara M, Kondoh T, Hosoda
K and Kohmura E: MicroRNA-10b is overexpressed in malignant glioma
and associated with tumor invasive factors, uPAR and RhoC. Int J
Cancer. 125:1407–1413. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Guessous F, Zhang Y, Kofman A, Catania A,
Li Y, Schiff D, Purow B and Abounader R: microRNA-34a is tumor
suppressive in brain tumors and glioma stem cells. Cell Cycle.
9:1031–1036. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B
and Song ZS: MiR-214 regulate gastric cancer cell proliferation,
migration and invasion by targeting PTEN. Cancer Cell Int.
13:682013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lu S, Gao Y, Huang X and Wang X:
Cantharidin exerts anti-hepatocellular carcinoma by miR-214
modulating macrophage polarization. Int J Biol Sci. 10:415–425.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang YS, Wang YH, Xia HP, Zhou SW,
Schmid-Bindert G and Zhou CC: MicroRNA-214 regulates the acquired
resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant
cell lines. Asian Pac J Cancer Prev. 13:255–260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xia H, Ooi LL and Hui KM: MiR-214 targets
β-catenin pathway to suppress invasion, stem-like traits and
recurrence of human hepatocellular carcinoma. PLoS One.
7:e442062012. View Article : Google Scholar
|
|
44
|
Zhang W, Qian JX, Yi HL, Yang ZD, Wang CF,
Chen JY, Wei XZ, Fu Q and Ma H: The microRNA-29 plays a central
role in osteosarcoma pathogenesis and progression. Mol Biol (Mosk).
46:622–627. 2012. View Article : Google Scholar
|
|
45
|
Bao YP, Yi Y, Peng LL, Fang J, Liu KB, Li
WZ and Luo HS: Roles of microRNA-206 in osteosarcoma pathogenesis
and progression. Asian Pac J Cancer Prev. 14:3751–3755. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhou L, Park J, Jang KY, Park HS, Wagle S,
Yang KH, Lee KB, Park BH and Kim JR: The overexpression of BAMBI
and its involvement in the growth and invasion of human
osteosarcoma cells. Oncol Rep. 30:1315–1322. 2013.PubMed/NCBI
|
|
47
|
Jones KB, Salah Z, Del Mare S, Galasso M,
Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, et
al: miRNA signatures associate with pathogenesis and progression of
osteosarcoma. Cancer Res. 72:1865–1877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Penna E, Orso F, Cimino D, Vercellino I,
Grassi E, Quaglino E, Turco E and Taverna D: miR-214 coordinates
melanoma progression by upregulating ALCAM through TFAP2 and
miR-148b downmodulation. Cancer Res. 73:4098–4111. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Derfoul A, Juan AH, Difilippantonio MJ,
Palanisamy N, Ried T and Sartorelli V: Decreased microRNA-214
levels in breast cancer cells coincides with increased cell
proliferation, invasion and accumulation of the Polycomb Ezh2
methyltransferase. Carcinogenesis. 32:1607–1614. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Juan AH, Kumar RM, Marx JG, Young RA and
Sartorelli V: MiR-14-dependent regulation of the polycomb protein
Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell.
36:61–74. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang J, Cogdell D, Yang D, Hu L, Li H,
Zheng H, Du X, Pang Y, Trent J, Chen K and Zhang W: Deletion of the
WWOX gene and frequent loss of its protein expression in human
osteosarcoma. Cancer Lett. 291:31–38. 2010. View Article : Google Scholar
|
|
52
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liu Z, Zhu J, Cao H, Ren H and Fang X:
miR-10b promotes cell invasion through RhoC-AKT signaling pathway
by targeting HOXD10 in gastric cancer. Int J Oncol. 40:1553–1560.
2012.PubMed/NCBI
|
|
54
|
Guessous F, Alvarado-Velez M,
Marcinkiewicz L, Zhang Y, Kim J, Heister S, Kefas B, Godlewski J,
Schiff D, Purow B and Abounader R: Oncogenic effects of miR-10b in
glioblastoma stem cells. J Neurooncol. 112:153–163. 2013.
View Article : Google Scholar : PubMed/NCBI
|
